Becton, Dickinson and Co. | BDX - Operating Profit

Stock Price
152.13
Daily Change
-2.72 -1.76%
Monthly
-3.88%
Yearly
-25.82%
Q2 Forecast
155.05

Becton, Dickinson and Co. reported $663M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 1.85B 399M Mar/2026
Agilent USD 353M 90M Dec/2025
Align Technology USD 224.71M 40.06M Dec/2025
AngioDynamics USD -2.51M 5.41M Sep/2025
Avanos Medical USD 24.77M 5.8M Dec/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Bio-Rad Laboratories USD 63.9M 13.2M Sep/2025
Boston Scientific USD 1.24B 203M Dec/2025
Cooper Companies USD 212.8M 72.4M Dec/2025
Danaher USD 1.34B 158M Mar/2026
Dentsply International USD 538M 26M Dec/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 514.7M 144.4M Mar/2026
Globus Medical USD 181.31M 298.83M Dec/2025
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 66M 54.24M Dec/2025
Intuitive Surgical USD 859.7M 5.6M Mar/2026
J&J USD 6.62B 1.03B Mar/2026
Masimo USD 83.9M 300K Dec/2025
Medtronic USD 1.74B 40M Dec/2025
Solventum Corp USD 105M 1.58B Dec/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD 36.34M 445.24M Dec/2025
Terumo JPY 43.88B 1.21B Dec/2025
Thermo Fisher Scientific USD 1.91B 389M Mar/2026
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025